Clinical Impression: Resolved Hepatobiliary Process, Likely Self-Limited Acute Cholecystitis or Viral Hepatitis
The most likely impression is a self-limited hepatobiliary process—either resolving acute cholecystitis (possibly acalculous), viral hepatitis (such as EBV), or transient biliary obstruction that has spontaneously resolved. The presence of urinary ketones and protein suggests metabolic stress during the acute phase and possible concurrent renal involvement or dehydration.
Diagnostic Reasoning
Primary Hepatobiliary Differential
Resolved acute cholecystitis is the leading consideration given the initial RUQ pain with elevated liver enzymes 1. The ACR guidelines emphasize that RUQ pain with elevated liver function tests typically indicates biliary disease, with acute cholecystitis being the most common etiology 1.
Transaminase elevation correlates with duration of biliary pain—the fact that pain resolved within a week and the patient returned asymptomatic suggests the acute process has passed 2. Studies show that ALT and AST levels correlate strongly with pain duration in choledocholithiasis (r=0.622-0.633, P<0.001) 2.
Normal lipase effectively excludes acute pancreatitis as a cause of the RUQ pain and elevated liver enzymes 3, 4. This is critical because pancreatic pathology would typically present with lipase elevation ≥3-fold the upper limit of normal 3.
Viral Hepatitis Consideration
EBV or other viral infections can present with RUQ pain and cholestatic liver enzyme patterns, mimicking bacterial cholecystitis 5. A 2024 case report demonstrated that EBV can cause gallbladder wall edema without gallstones, presenting identically to acute cholecystitis 5.
The urinalysis findings support a systemic viral process—ketones indicate metabolic stress from acute illness, while proteinuria may reflect viral-induced glomerular involvement or dehydration 5.
Metabolic Component
Urinary ketones suggest the patient experienced decreased oral intake during the acute pain episode, leading to ketosis from fasting or metabolic stress 6.
Proteinuria may be transient and related to the acute illness, dehydration, or could indicate underlying renal pathology requiring follow-up 6.
Recommended Next Steps
Immediate Assessment
Repeat liver function tests to document normalization or persistent elevation 6. The 2018 Gut guidelines recommend calculating FIB-4 or NAFLD fibrosis score if liver disease etiology remains unclear, with values <1.3 indicating low risk of advanced fibrosis 6.
Obtain viral hepatitis serologies (hepatitis A IgM, hepatitis B surface antigen, hepatitis C antibody) and consider EBV serology (VCA-IgM, heterophile antibody) if clinical suspicion exists 5.
Right upper quadrant ultrasound remains the first-line imaging modality with 96% accuracy for detecting gallstones 1. This will identify cholelithiasis, gallbladder wall thickening, or pericholecystic fluid that may have been present during the acute episode 1.
If Initial Workup is Negative or Equivocal
MRCP (MRI with magnetic resonance cholangiopancreatography) is superior to CT for biliary pathology evaluation, with 85-100% sensitivity for cholelithiasis/choledocholithiasis 1. This should be considered if ultrasound is unremarkable but clinical suspicion for biliary disease remains high 1.
HIDA scan with cholecystokinin may identify functional gallbladder disorders (biliary dyskinesia or hyperkinesia) if structural imaging is normal but symptoms recur 7. Biliary hyperkinesia with elevated gallbladder ejection fraction (>80%) can cause biliary colic and responds to cholecystectomy 7.
Follow-Up Considerations
Repeat urinalysis after resolution of acute illness to determine if proteinuria persists, which would warrant nephrology evaluation 6.
Monitor for symptom recurrence—if RUQ pain returns, proceed with imaging as outlined above 1.
Important Caveats
Do not assume normal imaging excludes biliary pathology—18% of patients with choledocholithiasis present within 6 hours of pain onset with normal or minimal LFT alterations, but repeat testing within 24 hours shows significant elevation (mean 10.5-fold increase in ALT) 2.
Consider non-hepatobiliary causes if workup remains negative—referred pain from thoracic pathology (empyema, discitis) can mimic RUQ pain with elevated alkaline phosphatase 8.
Age matters for fibrosis assessment—if evaluating for chronic liver disease, use higher FIB-4 cutoffs (<2.0) for patients over 65 years 6.